CollPlant Biotechnologies Stock Price

0.21 (2.26%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 20,553
Bid Price 8.50
Ask Price 14.50
News -
Day High 9.60


52 Week Range


Day Low 8.97
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CollPlant Biotechnologies Ltd CLGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.21 2.26% 9.51 16:30:00
Open Price Low Price High Price Close Price Prev Close
9.54 8.97 9.60 9.51 9.30
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
324 20,553 $ 9.35 $ 192,072 - 7.50 - 23.49
Last Trade Time Type Quantity Stock Price Currency
16:00:00 217 $ 9.51 USD


Draw Mode:

CollPlant Biotechnologies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 94.29M 9.91M 9.91M $ 15.64M $ 181.44k -0.87 70.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

CollPlant Biotechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.6510.318.849.4023,242-0.14-1.45%
1 Month10.4310.507.508.8431,948-0.92-8.82%
3 Months10.0014.777.5010.0035,308-0.49-4.9%
6 Months17.8818.307.5012.2254,719-8.37-46.81%
1 Year15.6523.497.5015.4648,332-6.14-39.23%
3 Years4.3324.263.349914.1337,3865.18119.63%
5 Years8.9524.263.1313.4930,2970.566.26%

CollPlant Biotechnologies Description

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

Your Recent History
CollPlant ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.